Seth Lederman - 27 Aug 2026 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
31 Aug 2026, 08:00:21 UTC
Prior SEC filing
09 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Seth Lederman

Key filing fact

Seth Lederman filed Form 4 for Tonix Pharmaceuticals Holding Corp. (TNXP) on 31 Aug 2026.

Key facts

  • This page summarizes Seth Lederman's Form 4 filing for Tonix Pharmaceuticals Holding Corp. (TNXP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Aug 2026, 08:00.

Change

  • Previous filing in this sequence was filed on 09 Jun 2026.
  • Current net transaction value: +$27,580.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001563420 Primary reporting owner

LEDERMAN SETH

Relationship
Chief Executive Officer, Director
Address
C/O TONIX PHARMACEUTICALS HOLDING CORP., 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS
Signature
/s/ Seth Lederman
Signature date
31 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNXP transaction

Common Stock, $0.001 par value

Purchase

Transaction value
$27,580
Shares
+2,000
Change %
+22%
Price
$13.79
Shares after
11,005
Date
27 Aug 2026
Ownership
By IRA Account
Footnotes
F1
TNXP holding

Common Stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
20,001
Date
27 Aug 2026
Ownership
Direct
TNXP holding

Common Stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1
Date
27 Aug 2026
Ownership
Lederman & Co.
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reporting person may be deemed a control person of this entity.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .